XSHG
603067
Market cap4.79bUSD
Jul 10, Last price
40.26CNY
1D
-6.83%
1Q
4.30%
Jan 2017
178.23%
IPO
713.33%
Name
Hubei Zhenhua Chemical Co Ltd
Chart & Performance
P/E
45.91
P/S
6.67
EPS
0.88
Div Yield, %
0.31%
Shrs. gr., 5y
11.42%
Rev. gr., 5y
28.82%
Revenues
4.54b
+11.53%
Net income
659m
+39.37%
CFO
329m
-1.18%
Dividend
Jun 24, 20250.13571 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hubei Zhenhua Chemical Co.,Ltd. primarily conducts its operations within China, specializing in the entire lifecycle of chromium salt products, from their development and manufacturing to their ultimate sale and distribution. Their comprehensive product portfolio includes a wide array of chromium-based compounds such as sodium bichromate, various forms of chromic acid anhydride (both crystalline and liquid), chrome oxide green, and potassium dichromate. Beyond these core offerings, the company also supplies vitamin K3, anhydrous sodium sulphate, and aluminium hydroxide. The firm boasts an international presence, exporting its goods to diverse global markets across Europe, the United States, Africa, and Southeast Asia. Established in 1967, Hubei Zhenhua Chemical Co.,Ltd. is headquartered in Huangshi, China, and was previously known as Huanghsi Zhenhua Chemical Industry Co., Ltd.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||